一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Advanced Science >>article
Advanced Science

Advanced Science

IF: 14.3
Download PDF

Design and Characterization of a Novel eEF2K Degrader with Potent Therapeutic Efficacy Against Triple-Negative Breast Cancer

Published:12 December 2023 DOI:
Changxin Zhong, Rongfeng Zhu, Ting Jiang, Sheng Tian, Xiaobao Zhao, Xiaoya Wan, Shilong Jiang, Zonglin Chen, Rong Gong, Linhao He, Jin-Ming Yang, Na Ye, Yan Cheng

Abstract

Dysregulated eEF2K expression is implicated in the pathogenesis of many human cancers, including triple-negative breast cancer (TNBC), making it a plausible therapeutic target. However, specific eEF2K inhibitors with potent anti-cancer activity have not been available so far. Targeted protein degradation has emerged as a new strategy for drug discovery. In this study, a novel small molecule chemical is designed and synthesized, named as compound C1, which shows potent activity in degrading eEF2K. C1 selectively binds to F8, L10, R144, C146, E229, and Y236 of the eEF2K protein and promotes its proteasomal degradation by increasing the interaction between eEF2K and the ubiquitin E3 ligase βTRCP in the form of molecular glue. C1 significantly inhibits the proliferation and metastasis of TNBC cells both in vitro and in vivo and in TNBC patient-derived organoids, and these antitumor effects are attributed to the degradation of eEF2K by C1. Additionally, combination treatment of C1 with paclitaxel, a commonly used chemotherapeutic drug, exhibits synergistic anti-tumor effects against TNBC. This study not only generates a powerful research tool to investigate the therapeutic potential of targeting eEF2K, but also provides a promising lead compound for developing novel drugs for the treatment of TNBC and other cancers.

Substances (5)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50
Pevonedistat 905579-51-3 C21H25N5O4S 201 suppliers $27.00-$4735.50

Similar articles

IF:10.5

Self-assembling mertansine prodrug improves tolerability and efficacy of chemotherapy against metastatic triple-negative breast cancer

Journal of Controlled Release Wei Ran , Xiaoyu Liu ,etc Published: 1 February 2020
IF:10

Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer

Advanced Healthcare Materials Jiali Gong, Danling Cheng,etc Published: 21 November 2024
IF:4.6

Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.

iScience Xu Yang,?Li Deng,etc Published: 16 October 2023
噶尔县| 兴城市| 兰溪市| 泸州市| 读书| 谢通门县| 墨竹工卡县| 黑龙江省| 黑龙江省| 中江县| 荥经县| 岳普湖县| 黄平县| 万年县| 庆阳市| 亳州市| 通渭县| 泽州县| 荆州市| 尚义县| 运城市| 纳雍县| 普定县| 克拉玛依市| 阳新县| 隆安县| 新乡县| 英德市| 翁源县| 泸州市| 鄱阳县| 卓资县| 遂昌县| 保定市| 汉中市| 雷州市| 定结县| 郸城县| 呼伦贝尔市| 铁岭县| 和平县|